ClinicalTrials.Veeva

Menu

Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications

R

Region Skane

Status

Active, not recruiting

Conditions

Opioid Abuse

Treatments

Drug: Naloxone Nasal Spray
Other: Historical control cohort

Study type

Observational

Funder types

Other

Identifiers

NCT03570099
2018/300

Details and patient eligibility

About

Death in overdose is the single most common cause of death in people using heroin. In Sweden, the number of drug-related overdose deaths has increased gradually since the early 1990s. The purpose of the study is to investigate the effects of a Naloxone distribution program in Skåne County. The primary issue is whether the project had an effect on overdose mortality and overdose related injuries.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • subjects treated at the Addiction centres of Skåne County
  • signed informed consent

Exclusion criteria

  • subjects unable to understand study information due to psychiatric co-morbidity or severe language difficulties

Trial design

2,000 participants in 2 patient groups

Prospective Naloxone cohort
Description:
The prospective cohort consists of study subjects receiving Naloxone nasal spray in the distribution program.
Treatment:
Drug: Naloxone Nasal Spray
Historical control cohort
Description:
Data from the historical control cohort will be collected from national registries years 2013-2017.
Treatment:
Other: Historical control cohort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems